Singapore- MEDICAL JAPAN 2018, one of the largest and most comprehensive trade show successfully concluded its fourth ed...
Daiichi Sankyo has has submitted a supplemental New Drug Application (sNDA) to Japan’s Ministry of Health, Labour ...
Takeda Pharmaceutical Company Limited has announced that it has entered into a research, development and commercial coll...
A group of researchers, at the University of Tokyo’s Graduate School of Engineering in collaboration with Dai Nipp...
A group of researchers from Osaka University, Japan has developed a sensing method with the potential to significantly c...
Iran’s Ministry of Health and the Japan International Cooperation Agency (JICA) have signed a Memorandum of Unders...
A team of scientists at Nagoya University, Japan has introduced substituted warped nanographene, which is soluble i...
Researchers from Shinshu University have found that, unlike conventional plates, the titanium fiber plates do not cause ...
Singapore – Takeda has started a new initiative aimed at helping inflammatory bowel disease patients sort thr...
YL Biologics (YLB), a joint venture by drugmaker Lupin and Yoshindo, has successfully completed the late phase clinical ...
Scottish firm TC BioPharm has inked a strategic collaboration with the Japan’s NIPRO Corporation to co-d...
The Japan Prize Foundation has announced Max D. Cooper, MD, as a laureate of the 2018 Japan Prize. Cooper will receive a...
Researchers at Florey Institute of Neuroscience and Mental Health, and University of Melbourne, Australia and Japanese N...
A team of researchers at the Institute of Industrial Science (IIS), the University of Tokyo, CNRS and INSERM, has report...
BiomX Ltd., a microbiome company, announced that it has exclusively sub-licensed a set of bacterial targets from JSR Cor...
A team of experts at the University of Tokyo's Institute of Industrial Science (IIS) has developed a new probe that coul...
Hitachi, Ltd. and Hokkaido University announced that it has obtained U.S. Food & Drug Administration (FDA) 510(k) cl...
Tokyo based Astellas Pharma Inc. recently announced the acquisition of Mitobridge, Inc. Astellas paid $225 million to ac...
